- Home
- RARE vs KSS Comparison
RARE vs KSS Comparison
Compare RARE & KSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RARE | KSS |
|---|---|---|
| Founded | 2010 | 1962 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.4B |
| IPO Year | 2014 | 1992 |
Fundamental Metrics
Financial Performance| Metric | RARE | KSS |
|---|---|---|
| Price | $22.74 | $18.63 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 19 | 14 |
| Target Price | ★ $73.11 | $16.08 |
| AVG Volume (30 Days) | ★ 4.0M | 3.5M |
| Earning Date | 02-12-2026 | 11-25-2025 |
| Dividend Yield | N/A | ★ 2.69% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.73 |
| Revenue | $630,598,000.00 | ★ $15,751,000,000.00 |
| Revenue This Year | $19.68 | N/A |
| Revenue Next Year | $19.44 | N/A |
| P/E Ratio | ★ N/A | $10.76 |
| Revenue Growth | ★ 20.63 | N/A |
| 52 Week Low | $18.41 | $6.04 |
| 52 Week High | $46.50 | $25.22 |
Technical Indicators
Market Signals| Indicator | RARE | KSS |
|---|---|---|
| Relative Strength Index (RSI) | 34.87 | 38.77 |
| Support Level | $22.40 | $19.28 |
| Resistance Level | $24.65 | $20.67 |
| Average True Range (ATR) | 1.53 | 1.15 |
| MACD | 0.00 | -0.36 |
| Stochastic Oscillator | 64.17 | 3.55 |
Price Performance
Historical ComparisonAbout RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About KSS Kohl's Corporation
Kohl's operates about 1,150 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also has a large digital sales operation. Women's apparel is Kohl's largest category, having generated 25% of its 2024 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.